ImmunologyOncoImmunologyPeer-reviewed
Preclinical Proof of Concept for a personalized SNAPTM-TIL (Specific Neo-Antigen Peptides -TIL) therapy platform
Tithi Ghosh, Erin Kelley, Jorge Soria‐Bustos…·Sunil Sharma
This paper demonstrates a personalized SNAP-TIL therapy platform that improves TIL efficacy by enriching them with neoantigen-reactive T-cells, achieving high CD3+ cell content and significant tumor growth inhibition in preclinical models.
DOI 10.1080/2162402x.2026.2684383